Not applicableStudy completedNCT01542333What this trial is testingStudying Biomarkers in Samples From Younger Patients With Wilms TumorWho this might be right forKidney Cancer Children's Oncology Group 20
Large-scale testing (Phase 3)Study completedNCT00072046What this trial is testingInterferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)Who this might be right forKidney Cancer Alliance for Clinical Trials in Oncology 732
Testing effectiveness (Phase 2)Looking for participantsNCT03175224What this trial is testingAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsWho this might be right forSolid TumorsAdvanced CancerRenal Cancer+15 more Apollomics Inc. 497
Testing effectiveness (Phase 2)Study completedNCT00378703What this trial is testingBevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7 National Cancer Institute (NCI) 361
Testing effectiveness (Phase 2)Ended earlyNCT01582009What this trial is testingPanobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib TosylateWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CancerStage III Renal Cell Cancer+1 more Roswell Park Cancer Institute 26
Testing effectiveness (Phase 2)WithdrawnNCT01639521What this trial is testingGemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial CancerWho this might be right forAnterior Urethral CancerLocalized Transitional Cell Cancer of the Renal Pelvis and UreterPosterior Urethral Cancer+7 more University of Southern California
Not applicableEnded earlyNCT00727532What this trial is testingSorafenib in Treating Patients With Locally Advanced or Metastatic Kidney CancerWho this might be right forHereditary Clear Cell Renal Cell CarcinomaKidney Cancer Northwestern University 9
Large-scale testing (Phase 3)Looking for participantsNCT07227402What this trial is testingA Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)Who this might be right forRenal Cell Carcinoma Merck Sharp & Dohme LLC 904
Large-scale testing (Phase 3)Ended earlyNCT01198158What this trial is testingEverolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line TherapyWho this might be right forClear Cell Renal Cell CarcinomaRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more National Cancer Institute (NCI) 77
Testing effectiveness (Phase 2)Looking for participantsNCT07049926What this trial is testingSubstudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)Who this might be right forRenal Cell Carcinoma Merck Sharp & Dohme LLC 140
Not applicableStudy completedNCT00900276What this trial is testingBiomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy ParticipantsWho this might be right forBladder CancerKidney CancerTransitional Cell Cancer of the Renal Pelvis and Ureter+1 more Wake Forest University Health Sciences 5
Testing effectiveness (Phase 2)Study completedNCT00478361What this trial is testingGemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney FunctionWho this might be right forDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterProximal Urethral Cancer+8 more M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT03513952What this trial is testingAtezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial CarcinomaWho this might be right forAdvanced Bladder Urothelial CarcinomaAdvanced Ureter Urothelial CarcinomaMetastatic Bladder Urothelial Carcinoma+21 more National Cancer Institute (NCI) 47
Not applicableStudy completedNCT00253708What this trial is testingMassage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic CancerWho this might be right forCancer Beth Israel Deaconess Medical Center 39
Testing effectiveness (Phase 2)Study completedNCT00100906What this trial is testingSequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell CancerWho this might be right forKidney Cancer H. Lee Moffitt Cancer Center and Research Institute 18
Early research (Phase 1)Active Not RecruitingNCT04514484What this trial is testingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVWho this might be right forAdvanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT00002515What this trial is testingCombination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare CancerWho this might be right forChildhood Germ Cell TumorExtragonadal Germ Cell TumorHead and Neck Cancer+8 more Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00002610What this trial is testingChemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney TumorsWho this might be right forKidney Cancer Children's Oncology Group 203
Early research (Phase 1)Study completedNCT00348699What this trial is testingAFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By SurgeryWho this might be right forMale Breast CancerRecurrent Breast CancerRecurrent Ovarian Epithelial Cancer+7 more National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Study completedNCT00045487What this trial is testingErlotinib in Treating Patients With Advanced Kidney CancerWho this might be right forKidney Cancer The University of Texas Health Science Center at San Antonio 41